David Wellman, MD
Sleep Medicine · Brighton, MANPI 1578596409
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,000 of the $19,387 with a category attached, or 87.7%. Inspire Medical Systems, Inc. accounts for 72.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $6,750 and has fallen 95.0% since, to $335 in 2025. Among sleep medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $1615.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$14K
- Novartis$3K
- Sanofi$2K
- Johnson & Johnson$300
Across 12 payments — averaging $22,729 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$270K
- Sanofi$2K
What the payments were for
- Consulting fees$17,00088%
- Speaking & faculty fees$2,00010%
- Food & beverage$3872%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 4 | $14,087 |
| Novartis | 1 | $3,000 |
| Sanofi | 2 | $2,000 |
| Johnson & Johnson | 5 | $300 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$14,000
- PROMACTA$3,000
- VA-LCP$149
- NA$149
How this compares
$19,387 in reported general payments places this provider in the 90th percentile of 51 sleep medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 14 | $433 |
| Gabapentin | 28 | $190 |
| Zolpidem Tartrate | 30 | $65 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Brighton
- John WinkelmanBoston$104K
- Suzanne BertischBoston$47K
- Robert ThomasBoston$36K
- Sogol JavaheriBoston$15K
- Neil ShoreSalem$9K
- Salma Batool AnwarBoston$5K
- Daniel GottliebBoston$4K
- Bethany BartleyBoston$4K
- Mustafa AlbakourBurlington$4K
- Stuart QuanBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.